Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph R Vassallo

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Transfusion|September 6, 2017
Comparison of donor and general population demographics over time: a BEST Collaborative group studyMindy Goldman, Whitney R Steele, Emanuele Di Angelantonio, et al.
Transfusion|November 4, 2016
An association between ABO group and HLA antibody detectionNancy M Dunbar, Mark H Yazer, Marjorie D Bravo, et al.
Transfusion|June 30, 2025
It is time to eliminate the one-hour corrected count increment in the diagnostic workup of platelet transfusion refractorinessRaeshun Glover, Bettie Yeboah, Ralph R Vassallo, et al.
Transfusion|October 28, 2024
Management of human leukocyte antigen-mediated platelet transfusion refractoriness: Brief synopsis and recent literature reviewSandhya R Panch, Ralph R Vassallo, Sharon Adams, et al.
Transfusion|January 5, 2019
Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries: a BEST Collaborative group studyMindy Goldman, Marc Germain, Yves Grégoire, et al.
Transfusion|November 8, 2022
Comparison of allocation strategies of convalescent plasma to reduce excess infections and mortality from SARS-CoV-2 in a US-like populationNatalya Kostandova, Emmanuel Fulgence Drabo, Karine Yenokyan, et al.
Transfusion|December 3, 2014
It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work GroupS Gerald Sandler, Willy A Flegel, Connie M Westhoff, et al.
Transfusion|January 13, 2011
Evaluation of overnight hold of whole blood at room temperature before component processing: effect of red blood cell (RBC) additive solutions on in vitro RBC measuresPieter F van der Meer, Jose A Cancelas, Rebecca Cardigan, et al.
Transfusion|March 13, 2020
It's time to phase out "serologic weak D phenotype" and resolve D types with RHD genotyping including weak D type 4Willy A Flegel, Gregory A Denomme, John T Queenan, et al.
Transfusion|August 14, 2012
In vitro and in vivo quality of leukoreduced apheresis platelets stored in a new platelet additive solutionLarry J Dumont, Jose A Cancelas, Sharon Graminske, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Transfusion|September 6, 2017
Comparison of donor and general population demographics over time: a BEST Collaborative group studyMindy Goldman, Whitney R Steele, Emanuele Di Angelantonio, et al.
Transfusion|November 4, 2016
An association between ABO group and HLA antibody detectionNancy M Dunbar, Mark H Yazer, Marjorie D Bravo, et al.
Transfusion|June 30, 2025
It is time to eliminate the one-hour corrected count increment in the diagnostic workup of platelet transfusion refractorinessRaeshun Glover, Bettie Yeboah, Ralph R Vassallo, et al.
Transfusion|October 28, 2024
Management of human leukocyte antigen-mediated platelet transfusion refractoriness: Brief synopsis and recent literature reviewSandhya R Panch, Ralph R Vassallo, Sharon Adams, et al.
Transfusion|January 5, 2019
Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries: a BEST Collaborative group studyMindy Goldman, Marc Germain, Yves Grégoire, et al.
Transfusion|November 8, 2022
Comparison of allocation strategies of convalescent plasma to reduce excess infections and mortality from SARS-CoV-2 in a US-like populationNatalya Kostandova, Emmanuel Fulgence Drabo, Karine Yenokyan, et al.
Transfusion|December 3, 2014
It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work GroupS Gerald Sandler, Willy A Flegel, Connie M Westhoff, et al.
Transfusion|January 13, 2011
Evaluation of overnight hold of whole blood at room temperature before component processing: effect of red blood cell (RBC) additive solutions on in vitro RBC measuresPieter F van der Meer, Jose A Cancelas, Rebecca Cardigan, et al.
Transfusion|March 13, 2020
It's time to phase out "serologic weak D phenotype" and resolve D types with RHD genotyping including weak D type 4Willy A Flegel, Gregory A Denomme, John T Queenan, et al.
Transfusion|August 14, 2012
In vitro and in vivo quality of leukoreduced apheresis platelets stored in a new platelet additive solutionLarry J Dumont, Jose A Cancelas, Sharon Graminske, et al.
Pageof 5